Daniela Furlan

10PUBLICATIONS
36CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 12, 2026
Molecular Profiling of Digestive Grade 3 Neuroendocrine Tumors Reveals a Shared Molecular Framework with Lower-Grade Tumors, Marked Heterogeneity, and Therapeutic Opportunities.

|Nov 27, 2024
LINE-1 hypomethylation characterizes the inflammatory response in coeliac disease associated-intestinal mucosa and small bowel adenocarcinomas.

Laura Libera, Alessandro Vanoli, Nora Sahnane

|Aug 28, 2024
Medullary carcinomas of the nonampullary small intestine: association with coeliac disease, mismatch repair deficiency, PD-L1 expression, and favourable prognosis.

Alessandro Vanoli, Federica Grillo, Giuseppe De Lisi

|Aug 26, 2022
Tumor Antigenicity and a Pre-Existing Adaptive Immune Response in Advanced BRAF Mutant Colorectal Cancers.

Elena Bolzacchini, Laura Libera, Sarah E Church

|Oct 13, 2021
Methylation Drivers and Prognostic Implications in Sinonasal Poorly Differentiated Carcinomas.

Laura Libera, Giorgia Ottini, Nora Sahnane

|Apr 30, 2021
MYD88L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation.

Martina Ferrante, Daniela Furlan, Silvia Zibellini

Pageof 2

Frequent Collaborators

4 joint publications

Laura Libera

3 joint publications

Catherine Klersy

3 joint publications

Antonio Di Sabatino

3 joint publications

Silvia Uccella